Generation of stable cell lines by site-specific integration of transgenes into engineered Chinese hamster ovary strains using an FLP-FRT system.

Random integration linking genomic amplification is widely used to generate desired cell lines for stable and high-level expressing recombinant proteins. But this technique is laborious, and the expression level is unpredictable due to position effects. After reading many reports on gene amplification, we hypothesized that there should be several loci in the genome of Chinese hamster ovary (CHO) cells that allow not only high-level, but also stable gene expression. Based on this hypothesis, we constructed a plasmid pMCEscan, which introduces a site-specific recombinase-recognition sequence, FRT, for gene targeting into those sites. Another targeting vector, pcDNA5/FRT, has an FRT sequence fused to a promoterless hygromycin-resistance gene that can be expressed only when correct gene targeting occurs. Using the pMCEscan, which is a novel and stringent selection system used to create a few high protein-producing clones, we constructed engineered CHO strains that can be used for high-level production of foreign proteins by gene targeting. We selected 28 CHO strains that expressed a high-level of reporter genes and carried one copy of the pMCEscan in their chromosomes, and we treated these strains with methotrexate (MTX) to evaluate dihydrofolate reductase (DHFR)-mediated gene amplification. Nine clones showed high-level tissue plasminogen activator (tPA) production without amplification. We then targeted other genes (tPA, secreted alkaline phosphatase (SEAP), erythropoietin (EPO)) to test the basal expression ability of nine CHO strains. CHO strains 8-1 and 8-11 consistently expressed high basal levels of the recombinant genes. Using this cell-vector system, we obtained the tPA stable high producers by gene targeting and gene amplification. This system allows for rapid generation of recombinant proteins without cloning and greatly simplifies selection of cell lines for the production of potential therapeutic proteins.

[1]  T. Omasa,et al.  Amplified Gene Location in Chromosomal DNA Affected Recombinant Protein Production and Stability of Amplified Genes , 2000, Biotechnology progress.

[2]  M. Page,et al.  High Level Expression of the Humanized Monoclonal Antibody CAMPATH-1H in Chinese Hamster Ovary Cells , 1991, Bio/Technology.

[3]  F. Wurm.  Production of recombinant protein therapeutics in cultivated mammalian cells , 2004, Nature Biotechnology.

[4]  T. Shibui,et al.  Construction of engineered CHO strains for high-level production of recombinant proteins , 2002, Applied Microbiology and Biotechnology.

[5]  C. Crowley,et al.  High-level production of recombinant proteins in CHO cells using a dicistronic DHFR intron expression vector. , 1996, Nucleic acids research.

[6]  Yan Li,et al.  An efficient and targeted gene integration system for high-level antibody expression. , 2007, Journal of immunological methods.

[7]  A. Ito,et al.  An accumulative site‐specific gene integration system using cre recombinase‐mediated cassette exchange , 2010, Biotechnology and bioengineering.

[8]  G. M. Lee,et al.  Clonal variability within dihydrofolate reductase-mediated gene amplified Chinese hamster ovary cells: stability in the absence of selective pressure. , 1998, Biotechnology and bioengineering.

[9]  B. Enenkel,et al.  Selection of high-producing CHO cells using NPT selection marker with reduced enzyme activity. , 2005, Biotechnology and bioengineering.

[10]  J. Piret,et al.  Limitations to the amplification and stability of human tissue-type plasminogen activator expression by Chinese hamster ovary cells. , 2000, Biotechnology and bioengineering.

[11]  R. Koduri,et al.  An efficient homologous recombination vector pTV(I) contains a hot spot for increased recombinant protein expression in Chinese hamster ovary cells. , 2001, Gene.

[12]  P. Little.  Small and perfectly formed , 1993, Nature.

[13]  C. Ryu,et al.  Characterization of chimeric antibody producing CHO cells in the course of dihydrofolate reductase-mediated gene amplification and their stability in the absence of selective pressure. , 1998, Biotechnology and bioengineering.

[14]  M. Kennard,et al.  The generation of stable, high MAb expressing CHO cell lines based on the artificial chromosome expression (ACE) technology , 2009, Biotechnology and bioengineering.

[15]  D. Russell,et al.  Targeted transgene insertion into human chromosomes by adeno-associated virus vectors , 2002, Nature Biotechnology.

[16]  B. Thyagarajan,et al.  Mammalian genomes contain active recombinase recognition sites. , 2000, Gene.

[17]  C. Gorman,et al.  Site-specific gene targeting for gene expression in eukaryotes. , 2000, Current opinion in biotechnology.

[18]  Dagmar Wirth,et al.  Road to precision: recombinase-based targeting technologies for genome engineering. , 2007, Current opinion in biotechnology.

[19]  M. Carrondo,et al.  The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange. , 2006, Journal of biotechnology.

[20]  W. Doerfler,et al.  A rapid optimized protocol for downward alkaline Southern blotting of DNA. , 1993, BioTechniques.

[21]  J. Lofgren,et al.  Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins , 1999, Nature Biotechnology.

[22]  D. Schübeler,et al.  The Transgeneticists Toolbox: Novel Methods for the Targeted Modification of Eukaryotic Genomes , 2000, Biological chemistry.